Homepagefrince2026-02-06T16:43:30+00:00

38^th EORTC-NCI-AACR

SYMPOSIUM 2026

on molecular targets and cancer therapeutics

Barcelona, Spain 18-20 November 2026

0

0

0

0

Days

0

0

Hours

0

0

Minutes

0

0

Seconds

About us - Illustration

About the Symposium

The 38^th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics will be held in person at the CCIB in Barcelona in November 2026.

Recognised as a leading forum for drug development and translational research, ENA 2026 will spotlight cutting-edge preclinical and phase I studies, fostering deep scientific exchange around emerging targets and novel therapeutics.

Bringing together a global community of researchers, clinicians, and industry experts, the Symposium offers a dynamic platform to explore the latest breakthroughs in molecular biology, target identification, and drug innovation.

1230

Participants

41

Countries

450+

Abstracts presented

30+

Hours of educational sessions

60+

International speakers

Reasons to Participate

Discover why ENA 2026 is the premier event for cancer research and drug development

Leading the way

Driving the discussion on cancer drug development

Ground-breaking data

Scientific evidence powering the latest progress

Networking

Expand your global network

Influencing research

Influence the future of clinical cancer research

Programme

Plan your sessions by viewing the latest searchable programme

Searchable Programme

View the latest searchable programme to plan your sessions and view abstracts.

Key Dates

1 April
Abstract submission opens
29 May
Early rate registration
26 June
Abstract submission closes
4 September
Regular rate registration closes

Meet the Chairs

Featuring 60+ global expert speakers shaping drug development and translational research

Elena Garralda

Chair, ENA 2026

Elena Garralda

Ryan Corcoran

Co-Chair [AACR]

Ryan Corcoran

tgwhite.

Co-Chair [NCI]

Tim Greten

Organisers and Partners

Hosted in collaboration with leading cancer research organisations